Cargando…
Lysyl oxidase‐like 2 inhibitor rescues D‐galactose‐induced skeletal muscle fibrosis
Aging‐related sarcopenia is currently the most common sarcopenia. The main manifestations are skeletal muscle atrophy, replacement of muscle fibers with fat and fibrous tissue. Excessive fibrosis can impair muscle regeneration and function. Lysyl oxidase‐like 2 (LOXL2) has previously been reported t...
Autores principales: | Wu, Yongxin, Wu, Yaoxuan, Yang, Yunfei, Yu, Jing, Wu, Jianghao, Liao, Zhiyin, Guo, Ai, Sun, Yue, Zhao, Yuxing, Chen, Jinliang, Xiao, Qian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9282848/ https://www.ncbi.nlm.nih.gov/pubmed/35712918 http://dx.doi.org/10.1111/acel.13659 |
Ejemplares similares
-
Targeting lysyl oxidase reduces peritoneal fibrosis
por: Harlow, Christopher R., et al.
Publicado: (2017) -
Lysyl oxidase family members in urological tumorigenesis and fibrosis
por: Li, Tao, et al.
Publicado: (2018) -
Fibrosis in Mesothelioma: Potential Role of Lysyl Oxidases
por: Perryman, Lara, et al.
Publicado: (2022) -
The Interactome of Cancer-Related Lysyl Oxidase and Lysyl Oxidase-Like Proteins
por: Vallet, Sylvain D., et al.
Publicado: (2020) -
Multifunctional Lysyl Oxidases
por: Trackman, Philip C.
Publicado: (2023)